Lista de obras -

Aetiology, timing and clinical predictors of early vs. late readmission following index hospitalization for acute heart failure: insights from ASCEND-HF.

artículo científico publicado en 2017

Anticoagulation in heart failure: current status and future direction

artículo científico publicado en 2013

Applicability of US Food and Drug Administration Labeling for Dapagliflozin to Patients With Heart Failure With Reduced Ejection Fraction in US Clinical Practice: The Get With the Guidelines-Heart Failure (GWTG-HF) Registry

artículo científico publicado en 2020

Association between funding sources and the scope and outcomes of cardiovascular clinical trials: A systematic review

artículo científico publicado en 2016

Association of arginine vasopressin levels with outcomes and the effect of V2 blockade in patients hospitalized for heart failure with reduced ejection fraction: insights from the EVEREST trial

artículo científico publicado en 2012

Body Weight Change During and After Hospitalization for Acute Heart Failure: Patient Characteristics, Markers of Congestion, and Outcomes: Findings From the ASCEND-HF Trial

artículo científico publicado en 2017

Changes in Dyspnea Status During Hospitalization and Postdischarge Health-Related Quality of Life in Patients Hospitalized for Heart Failure: Findings From the EVEREST Trial

artículo científico

Cinaciguat, a soluble guanylate cyclase activator: results from the randomized, controlled, phase IIb COMPOSE programme in acute heart failure syndromes ⬇️

artículo científico publicado el 19 de junio de 2012

Clinical profile and prognostic significance of natriuretic peptide trajectory following hospitalization for worsening chronic heart failure: findings from the ASTRONAUT trial

artículo científico publicado en 2015

Clinical profile and prognostic value of anemia at the time of admission and discharge among patients hospitalized for heart failure with reduced ejection fraction: findings from the EVEREST trial

artículo científico publicado en 2014

Clinical profile and prognostic value of low systolic blood pressure in patients hospitalized for heart failure with reduced ejection fraction: Insights from the Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan (EVERE

article

Clinical trials in hospitalized heart failure patients: targeting interventions to optimal phenotypic subpopulations

artículo científico

Contemporary cardiovascular device clinical trials (trends and patterns 2001 to 2012).

artículo científico publicado en 2015

Coronary artery disease in patients with heart failure: incidental, coincidental, or a target for therapy?

artículo científico publicado en 2014

Designing effective drug and device development programs for hospitalized heart failure: a proposal for pretrial registries

artículo científico publicado en 2014

Do Women and Men Respond Similarly to Therapies in Contemporary Heart Failure Clinical Trials?

scientific article published on 01 March 2019

Dose of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers and Outcomes in Heart Failure: A Meta-Analysis

artículo científico publicado en 2017

Drug Development for Heart Failure With Preserved Ejection Fraction: What Pieces Are Missing From the Puzzle?

artículo científico publicado en 2017

Effect of Vericiguat, a Soluble Guanylate Cyclase Stimulator, on Natriuretic Peptide Levels in Patients With Worsening Chronic Heart Failure and Reduced Ejection Fraction: The SOCRATES-REDUCED Randomized Trial

artículo científico publicado en 2015

Effect of aliskiren on post-discharge outcomes among diabetic and non-diabetic patients hospitalized for heart failure: insights from the ASTRONAUT trial

scientific article published on 02 September 2013

Effect of aliskiren on postdischarge mortality and heart failure readmissions among patients hospitalized for heart failure: the ASTRONAUT randomized trial

artículo científico

Effect of oral digoxin in high-risk heart failure patients: a pre-specified subgroup analysis of the DIG trial

artículo científico publicado en 2013

Enrollment of Older Patients, Women, and Racial and Ethnic Minorities in Contemporary Heart Failure Clinical Trials: A Systematic Review

artículo científico publicado en 2018

Enrollment of Older Patients, Women, and Racial/Ethnic Minority Groups in Contemporary Acute Coronary Syndrome Clinical Trials: A Systematic Review

scientific article published on 25 March 2020

Erratum to 'The role of angiotensin receptor-neprilysin inhibitors in cardiovascular disease-existing evidence, knowledge gaps, and future directions' [Eur J Heart Fail 2018;20:963-972]

artículo científico publicado en 2019

Expert consensus document: Mitochondrial function as a therapeutic target in heart failure

scientific article published on 22 December 2016

Global variation in clinical profile, management, and post-discharge outcomes among patients hospitalized for worsening chronic heart failure: findings from the ASTRONAUT trial

artículo científico publicado en 2015

Haemoconcentration, renal function, and post-discharge outcomes among patients hospitalized for heart failure with reduced ejection fraction: insights from the EVEREST trial

artículo científico publicado en 2013

Haemodynamic effects, safety, and pharmacokinetics of human stresscopin in heart failure with reduced ejection fraction†

Heart Failure End Points in Cardiovascular Outcome Trials of Sodium Glucose Cotransporter 2 Inhibitors in Patients With Type 2 Diabetes Mellitus: A Critical Evaluation of Clinical and Regulatory Issues

scientific article published on 16 December 2019

Heart Failure Site-Based Research in the United States: Results of the Heart Failure Society of America Research Network Survey

scientific article published on 10 April 2019

Hemoconcentration-guided diuresis in heart failure

artículo científico publicado en 2014

High-Sensitivity Troponin I in Hospitalized and Ambulatory Patients With Heart Failure With Preserved Ejection Fraction: Insights From the Heart Failure Clinical Research Network.

artículo científico publicado en 2018

History of Atrial Fibrillation and Trajectory of Decongestion in Acute Heart Failure

artículo científico publicado en 2018

Hospitalization for Recently Diagnosed Versus Worsening Chronic Heart Failure: From the ASCEND-HF Trial

artículo científico

Impact of diabetes on epidemiology, treatment, and outcomes of patients with heart failure

artículo científico

In-hospital worsening heart failure

artículo científico

Influence of Clinical Trial Site Enrollment on Patient Characteristics, Protocol Completion, and End Points: Insights From the ASCEND-HF Trial (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure).

artículo científico

Influence of atrial fibrillation on post-discharge natriuretic peptide trajectory and clinical outcomes among patients hospitalized for heart failure: insights from the ASTRONAUT trial.

artículo científico publicado en 2016

Is Time of the Essence? The Impact of Time of Hospital Presentation in Acute Heart Failure: Insights From ASCEND-HF Trial

artículo científico publicado en 2018

Length of hospital stay and 30-day readmission following heart failure hospitalization: insights from the EVEREST trial

artículo científico publicado en 2015

Lipids, statins, and clinical outcomes in heart failure: rethinking the data

artículo científico publicado en 2014

Medical Therapy for Heart Failure With Reduced Ejection Fraction: The CHAMP-HF Registry

scientific article published on 01 July 2018

Mineralocorticoid receptor antagonist use in hospitalized patients with heart failure, reduced ejection fraction, and diabetes mellitus (from the EVEREST Trial)

artículo científico publicado en 2014

Outpatient versus inpatient worsening heart failure: distinguishing biology and risk from location of care

artículo científico publicado en 2018

Partial adenosine A1 receptor agonism: a potential new therapeutic strategy for heart failure

artículo científico

Plasma renin activity, response to aliskiren, and clinical outcomes in patients hospitalized for heart failure: the ASTRONAUT trial.

artículo científico publicado en 2017

Post-discharge haemodilution, congestion, and clinical outcomes among patients hospitalized for heart failure with reduced ejection fraction: results from the EVEREST trial

scientific article published on 03 December 2019

Pre-discharge and early post-discharge troponin elevation among patients hospitalized for heart failure with reduced ejection fraction: findings from the ASTRONAUT trial

artículo científico publicado en 2017

Predictive Value of Low Relative Lymphocyte Count in Patients Hospitalized for Heart Failure With Reduced Ejection Fraction

article

Prognostic Value of Monocyte Count in Patients Hospitalized for Heart Failure With Reduced Ejection Fraction (from the EVEREST Trial)

Prognostic significance of serum total cholesterol and triglyceride levels in patients hospitalized for heart failure with reduced ejection fraction (from the EVEREST Trial).

artículo científico publicado en 2012

Reassessing the Role of Surrogate End Points in Drug Development for Heart Failure

article

Relation of serum magnesium levels and postdischarge outcomes in patients hospitalized for heart failure (from the EVEREST Trial).

artículo científico publicado en 2013

Relation of serum uric acid levels and outcomes among patients hospitalized for worsening heart failure with reduced ejection fraction (from the efficacy of vasopressin antagonism in heart failure outcome study with tolvaptan trial).

artículo científico publicado en 2014

Relationship Between Enrolling Country Income Level and Patient Profile, Protocol Completion, and Trial End Points

article

Relationship between timing of trial randomization, protocol completion, and clinical outcomes among patients hospitalized for heart failure: from the ASTRONAUT trial

artículo científico publicado en 2018

Renin-angiotensin blockade in heart failure with preserved ejection fraction: a systematic review and meta-analysis

artículo científico publicado en 2017

Representation of Women Authors in International Heart Failure Guidelines and Contemporary Clinical Trials

artículo científico publicado en 2020

Representativeness of a Heart Failure Trial by Race and Sex: Results From ASCEND-HF and GWTG-HF

scientific article published on 09 October 2019

Serum Osmolality and Postdischarge Outcomes After Hospitalization for Heart Failure

artículo científico publicado en 2016

Site selection for heart failure clinical trials in the USA.

artículo científico publicado en 2015

Site selection in global clinical trials in patients hospitalized for heart failure: perceived problems and potential solutions

artículo científico publicado en 2014

Soluble guanylate cyclase: a potential therapeutic target for heart failure

artículo científico publicado en 2013

Sudden Death After Hospitalization for Heart Failure With Reduced Ejection Fraction (from the EVEREST Trial)

Temporal Changes in Postdischarge Mortality Risk After Hospitalization for Heart Failure (from the EVEREST Trial).

artículo científico publicado en 2015

The clinical course of health status and association with outcomes in patients hospitalized for heart failure: insights from ASCEND-HF

artículo científico publicado en 2015

The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries.

artículo científico publicado en 2014

The prognostic significance of heart rate in patients hospitalized for heart failure with reduced ejection fraction in sinus rhythm: insights from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study With Tolvaptan) trial.

artículo científico publicado en 2013

The role of angiotensin receptor-neprilysin inhibitors in cardiovascular disease-existing evidence, knowledge gaps, and future directions

artículo científico publicado en 2018

The vulnerable phase after hospitalization for heart failure

artículo científico

Trajectory of Congestion Metrics by Ejection Fraction in Patients With Acute Heart Failure (from the Heart Failure Network).

artículo científico publicado en 2017

Treatment of HF in an Era of Multiple Therapies: Statement From the HF Collaboratory

scientific article published on 09 December 2020

Trends in Heart Failure Clinical Trials From 2001-2012.

artículo científico

Trends in prevalence of comorbidities in heart failure clinical trials

artículo científico publicado en 2020

Water and sodium in heart failure: a spotlight on congestion

artículo científico publicado en 2015

Lista de obras de

Aetiology, timing and clinical predictors of early vs. late readmission following index hospitalization for acute heart failure: insights from ASCEND-HF.

Anticoagulation in heart failure: current status and future direction

Applicability of US Food and Drug Administration Labeling for Dapagliflozin to Patients With Heart Failure With Reduced Ejection Fraction in US Clinical Practice: The Get With the Guidelines-Heart Failure (GWTG-HF) Registry

Association between funding sources and the scope and outcomes of cardiovascular clinical trials: A systematic review

Association of arginine vasopressin levels with outcomes and the effect of V2 blockade in patients hospitalized for heart failure with reduced ejection fraction: insights from the EVEREST trial

Body Weight Change During and After Hospitalization for Acute Heart Failure: Patient Characteristics, Markers of Congestion, and Outcomes: Findings From the ASCEND-HF Trial

Changes in Dyspnea Status During Hospitalization and Postdischarge Health-Related Quality of Life in Patients Hospitalized for Heart Failure: Findings From the EVEREST Trial

Cinaciguat, a soluble guanylate cyclase activator: results from the randomized, controlled, phase IIb COMPOSE programme in acute heart failure syndromes ⬇️

Clinical profile and prognostic significance of natriuretic peptide trajectory following hospitalization for worsening chronic heart failure: findings from the ASTRONAUT trial

Clinical profile and prognostic value of anemia at the time of admission and discharge among patients hospitalized for heart failure with reduced ejection fraction: findings from the EVEREST trial

Clinical profile and prognostic value of low systolic blood pressure in patients hospitalized for heart failure with reduced ejection fraction: Insights from the Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan (EVERE

Clinical trials in hospitalized heart failure patients: targeting interventions to optimal phenotypic subpopulations

Contemporary cardiovascular device clinical trials (trends and patterns 2001 to 2012).

Coronary artery disease in patients with heart failure: incidental, coincidental, or a target for therapy?

Designing effective drug and device development programs for hospitalized heart failure: a proposal for pretrial registries

Do Women and Men Respond Similarly to Therapies in Contemporary Heart Failure Clinical Trials?

Dose of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers and Outcomes in Heart Failure: A Meta-Analysis

Drug Development for Heart Failure With Preserved Ejection Fraction: What Pieces Are Missing From the Puzzle?

Effect of Vericiguat, a Soluble Guanylate Cyclase Stimulator, on Natriuretic Peptide Levels in Patients With Worsening Chronic Heart Failure and Reduced Ejection Fraction: The SOCRATES-REDUCED Randomized Trial

Effect of aliskiren on post-discharge outcomes among diabetic and non-diabetic patients hospitalized for heart failure: insights from the ASTRONAUT trial

Effect of aliskiren on postdischarge mortality and heart failure readmissions among patients hospitalized for heart failure: the ASTRONAUT randomized trial

Effect of oral digoxin in high-risk heart failure patients: a pre-specified subgroup analysis of the DIG trial

Enrollment of Older Patients, Women, and Racial and Ethnic Minorities in Contemporary Heart Failure Clinical Trials: A Systematic Review

Enrollment of Older Patients, Women, and Racial/Ethnic Minority Groups in Contemporary Acute Coronary Syndrome Clinical Trials: A Systematic Review

Erratum to 'The role of angiotensin receptor-neprilysin inhibitors in cardiovascular disease-existing evidence, knowledge gaps, and future directions' [Eur J Heart Fail 2018;20:963-972]

Expert consensus document: Mitochondrial function as a therapeutic target in heart failure

Global variation in clinical profile, management, and post-discharge outcomes among patients hospitalized for worsening chronic heart failure: findings from the ASTRONAUT trial

Haemoconcentration, renal function, and post-discharge outcomes among patients hospitalized for heart failure with reduced ejection fraction: insights from the EVEREST trial

Haemodynamic effects, safety, and pharmacokinetics of human stresscopin in heart failure with reduced ejection fraction†

Heart Failure End Points in Cardiovascular Outcome Trials of Sodium Glucose Cotransporter 2 Inhibitors in Patients With Type 2 Diabetes Mellitus: A Critical Evaluation of Clinical and Regulatory Issues

Heart Failure Site-Based Research in the United States: Results of the Heart Failure Society of America Research Network Survey

Hemoconcentration-guided diuresis in heart failure

High-Sensitivity Troponin I in Hospitalized and Ambulatory Patients With Heart Failure With Preserved Ejection Fraction: Insights From the Heart Failure Clinical Research Network.

History of Atrial Fibrillation and Trajectory of Decongestion in Acute Heart Failure

Hospitalization for Recently Diagnosed Versus Worsening Chronic Heart Failure: From the ASCEND-HF Trial

Impact of diabetes on epidemiology, treatment, and outcomes of patients with heart failure

In-hospital worsening heart failure

Influence of Clinical Trial Site Enrollment on Patient Characteristics, Protocol Completion, and End Points: Insights From the ASCEND-HF Trial (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure).

Influence of atrial fibrillation on post-discharge natriuretic peptide trajectory and clinical outcomes among patients hospitalized for heart failure: insights from the ASTRONAUT trial.

Is Time of the Essence? The Impact of Time of Hospital Presentation in Acute Heart Failure: Insights From ASCEND-HF Trial

Length of hospital stay and 30-day readmission following heart failure hospitalization: insights from the EVEREST trial

Lipids, statins, and clinical outcomes in heart failure: rethinking the data

Medical Therapy for Heart Failure With Reduced Ejection Fraction: The CHAMP-HF Registry

Mineralocorticoid receptor antagonist use in hospitalized patients with heart failure, reduced ejection fraction, and diabetes mellitus (from the EVEREST Trial)

Outpatient versus inpatient worsening heart failure: distinguishing biology and risk from location of care

Partial adenosine A1 receptor agonism: a potential new therapeutic strategy for heart failure

Plasma renin activity, response to aliskiren, and clinical outcomes in patients hospitalized for heart failure: the ASTRONAUT trial.

Post-discharge haemodilution, congestion, and clinical outcomes among patients hospitalized for heart failure with reduced ejection fraction: results from the EVEREST trial

Pre-discharge and early post-discharge troponin elevation among patients hospitalized for heart failure with reduced ejection fraction: findings from the ASTRONAUT trial

Predictive Value of Low Relative Lymphocyte Count in Patients Hospitalized for Heart Failure With Reduced Ejection Fraction

Prognostic Value of Monocyte Count in Patients Hospitalized for Heart Failure With Reduced Ejection Fraction (from the EVEREST Trial)

Prognostic significance of serum total cholesterol and triglyceride levels in patients hospitalized for heart failure with reduced ejection fraction (from the EVEREST Trial).

Reassessing the Role of Surrogate End Points in Drug Development for Heart Failure

Relation of serum magnesium levels and postdischarge outcomes in patients hospitalized for heart failure (from the EVEREST Trial).

Relation of serum uric acid levels and outcomes among patients hospitalized for worsening heart failure with reduced ejection fraction (from the efficacy of vasopressin antagonism in heart failure outcome study with tolvaptan trial).

Relationship Between Enrolling Country Income Level and Patient Profile, Protocol Completion, and Trial End Points

Relationship between timing of trial randomization, protocol completion, and clinical outcomes among patients hospitalized for heart failure: from the ASTRONAUT trial

Renin-angiotensin blockade in heart failure with preserved ejection fraction: a systematic review and meta-analysis

Representation of Women Authors in International Heart Failure Guidelines and Contemporary Clinical Trials

Representativeness of a Heart Failure Trial by Race and Sex: Results From ASCEND-HF and GWTG-HF

Serum Osmolality and Postdischarge Outcomes After Hospitalization for Heart Failure

Site selection for heart failure clinical trials in the USA.

Site selection in global clinical trials in patients hospitalized for heart failure: perceived problems and potential solutions

Soluble guanylate cyclase: a potential therapeutic target for heart failure

Sudden Death After Hospitalization for Heart Failure With Reduced Ejection Fraction (from the EVEREST Trial)

Temporal Changes in Postdischarge Mortality Risk After Hospitalization for Heart Failure (from the EVEREST Trial).

The clinical course of health status and association with outcomes in patients hospitalized for heart failure: insights from ASCEND-HF

The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries.

The prognostic significance of heart rate in patients hospitalized for heart failure with reduced ejection fraction in sinus rhythm: insights from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study With Tolvaptan) trial.

The role of angiotensin receptor-neprilysin inhibitors in cardiovascular disease-existing evidence, knowledge gaps, and future directions

The vulnerable phase after hospitalization for heart failure

Trajectory of Congestion Metrics by Ejection Fraction in Patients With Acute Heart Failure (from the Heart Failure Network).

Treatment of HF in an Era of Multiple Therapies: Statement From the HF Collaboratory

Trends in Heart Failure Clinical Trials From 2001-2012.

Trends in prevalence of comorbidities in heart failure clinical trials

Water and sodium in heart failure: a spotlight on congestion